يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Hans-Jürgen, Welkoborsky"', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 1
    Position paper: Suggestions for patient information and education before application of biologics in chronic rhinosinusitis with nasal polyps (CRSwNP) - Part 2: Omalizumab. Recommendations of the Medical Association of German Allergologists (AeDA) and the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKHC)

    المؤلفون: Christoph Bergmann, Adam Chaker, Thomas Deitmer, Martin Wagenmann, Thomas K. Hoffmann, Annette Sperl, Heidi Olze, Stefan Dazert, Claudia Rudack, Karl Christian Bergmann, Achim G. Beule, Ludger Klimek, Holger Wrede, U Förster-Ruhrmann, Tilman Huppertz, Sven Becker, Andreas Dietz, T. Zuberbier, Anna Bedbrook, Claus Bachert, Ingrid Casper, Barbara Wollenberg, Jean Bousquet, Hans Jürgen Welkoborsky, Wolfgang Schlenter, Jan Hagemann

    المساهمون: Vieillissement et Maladies chroniques : approches épidémiologique et de santé publique (VIMA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)

    المصدر: Laryngo-Rhino-Otologie
    Laryngo-Rhino-Otologie, Georg Thieme Verlag, 2021, 100 (11), pp.864-872. ⟨10.1055/a-1592-0316⟩

    مصطلحات موضوعية: medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), COVID19, Chronic rhinosinusitis, [SDV]Life Sciences [q-bio], Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Omalizumab, Dupilumab, 03 medical and health sciences, 0302 clinical medicine, medicine, 030223 otorhinolaryngology, Mepolizumab, Gynecology, business.industry, Biologika, chronische Rhinosinusitis, CRSwNP, Benralizumab, 3. Good health, Endotyp-Klassifizierung, 030228 respiratory system, Otorhinolaryngology, Passive sensitization, business, Rhinosurgery, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::970ff9b6fe157c2c152812aa1139f439Test
    https://doi.org/10.1055/a-1592-0316Test


    أضف إلى المفضلة
  2. 2
    Position paper: Suggestions for patient information and education before application of biologics in chronic rhinosinusitis with nasal polyps (CRSwNP): Recommendations of the Medical Association of German Allergologists (AeDA) and the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKHC) - Part 1: Dupilumab

    المؤلفون: Claudia Rudack, Anna Bedbrook, Sven Becker, Karl Christian Bergmann, Barbara Wollenberg, Adam Chaker, Ingrid Casper, U Förster-Ruhrmann, Stefan Dazert, Heidi Olze, Wolfgang Schlenter, Annette Sperl, Ludger Klimek, Martin Wagenmann, Thomas K. Hoffmann, Andreas Dietz, Thomas Deitmer, Hans Jürgen Welkoborsky, Holger Wrede, Jean Bousquet, Jan Hagemann, T. Zuberbier, Claus Bachert, Achim G. Beule, Tilman Huppertz

    المساهمون: Zentrum für Rhinologie und Allergologie [Wiesbaden, Germany], University Hospital Münster - Universitaetsklinikum Muenster [Germany] (UKM), Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], Universitätsklinikum Tübingen - University Hospital of Tübingen, Eberhard Karls Universität Tübingen = Eberhard Karls University of Tuebingen, Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM), Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Universitätsklinikum Ulm - University Hospital of Ulm, Universitätsklinikum Knappschaftskrankenhaus [Bochum], Klinikum Region Hannover, University Hospital Leipzig, University Hospital Düsseldorf, Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Université Montpellier 1 (UM1)-Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)-European Innovation Partnership on Active and Healthy Ageing Reference Site (EIP on AHA), Commission Européenne-Commission Européenne-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Vieillissement et Maladies chroniques : approches épidémiologique et de santé publique (VIMA), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), University Hospital Gent, Universitätsklinikum Knappschaftskrankenhaus = University Hospital Knappschaftskrankenhaus [Bochum], Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-European Innovation Partnership on Active and Healthy Ageing Reference Site (EIP on AHA), Commission Européenne-Commission Européenne-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)

    المصدر: Laryngo-Rhino-Otologie
    Laryngo-Rhino-Otologie, Georg Thieme Verlag, 2020, 99 (11), pp.761-766. ⟨10.1055/a-1240-9304⟩

    مصطلحات موضوعية: Gynecology, medicine.medical_specialty, business.industry, Dupilumab, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, 030228 respiratory system, Otorhinolaryngology, medicine, [SHS.LANGUE]Humanities and Social Sciences/Linguistics, 030223 otorhinolaryngology, business, Mepolizumab, ComputingMilieux_MISCELLANEOUS, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e99f096ac105502ae4bd6626158d2cecTest
    https://hal.archives-ouvertes.fr/hal-03032403Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث